Detox pathway support: Plays a role in the bodys natural detoxification processes
64% of large firms say GLP-1 drug coverage moderately or significantly impacted their prescription drug spending Similar to the findings on use, 43% of firms with 1,000 to 4,999 workers, and 66% of firms with 5,000 or more workers, say that covering GLP-1 agonists for weight loss had a significant impact on the health plans prescription drug spending
majority of these firms are based in China (36%) and the US (28%)
It mimics the N-terminal end of SNAP-25, a component of the SNARE complex that controls neurotransmitter release at the neuromuscular junction
Genetic ablation of the Cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival, and tumor formation via nutrient and oxidative stresses
J Neuroimmunol 2008